A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults

BACKGROUND: To determine an appropriate dose of, and immunization schedule for, a vaccine SCoK against COVID‐19 for an efficacy study; herein, we conducted randomized controlled trials to assess the immunogenicity and safety of this vaccine in adults. METHODS: These randomized, double‐blind, placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Deyan, Pan, Hongxing, He, Peng, Yang, Xiaolan, Li, Tao, Ning, Nianzhi, Fang, Xin, Yu, Wenjing, Wei, Mingwei, Gao, Hui, Wang, Xin, Gu, Hongjing, Mei, Maodong, Li, Xinwang, Zhang, Liangyan, Li, Deyu, Gao, Chunrun, Gao, Jinbang, Fei, Guoqiang, Li, Ying, Yang, Yuguo, Xu, Yi, Wei, Wenjin, Sun, Yansong, Zhu, Fengcai, Hu, Zhongyu, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473350/
https://www.ncbi.nlm.nih.gov/pubmed/36103390
http://dx.doi.org/10.1002/ctm2.1016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473350/
https://www.ncbi.nlm.nih.gov/pubmed/36103390
http://dx.doi.org/10.1002/ctm2.1016

Ejemplares similares